Prevalence of anal cytologic abnormalities in a French referral population: A prospective study with special emphasis on HIV, HPV, and smoking

Diseases of the Colon and Rectum

Volumn 51, Issue 1, 2008, Pages 67-72

  Etienney, Isabelle ^a   Vuong, Sarra ^b   Daniel, Fady ^a   Mory, Benoît ^a   Taouk, Milad ^a   Sultan, Samy ^a   Thomas, Christian ^a   Bourguignon, Josée ^a   De Parades, Vincent ^a   Méary, Nathalie ^a   Balaton, André ^b   Atienza, Patrick ^a   Bauer, Pierre ^a  

^a GROUPE HOSPITALIER DIACONESSES CROIX SAINT SIMON   (France)

^b Centre de Pathologie   (France)

Author keywords

Anal pap smear; Cytologic abnormalities; Prevalence; Smoking

Indexed keywords

ADULT; AGED; ANUS CANCER; ANUS FISSURE; ANUS FISTULA; ARTICLE; CIGARETTE SMOKING; CONDYLOMA; CYTOLOGY; DYSPLASIA; FEMALE; HEMORRHOID; HIGH RISK PATIENT; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCONTINENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRURITUS; WART VIRUS;

ANUS DISEASES; CHI-SQUARE DISTRIBUTION; FEMALE; FRANCE; HIV INFECTIONS; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; POLYETHYLENE TEREPHTHALATES; PRECANCEROUS CONDITIONS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 38349054299     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-007-9098-y     Document Type: Article

References (22)

1. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and ends results experience, 1973-2000. Cancer 2004;101:281-8.
2. Chiao EY, Giordano TP, Palefsky JM, Tyring S, El Serag H. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis 2006;43:223-33.
3. Palefsky JM. Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem. AIDS 1994;8:283-95.
4. Cain JM, Howett MK. Preventing cervical cancer. Science 2000;288:1753-4.
5. Palefsky JM, Holly EA, Hogeboom CJ, Berry JM, Jay N, Darragh TM. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:415-22.
6. Friedlander MA, Stier E, Lin O. Anorectal cytology as a screening tool for anal squamous lesions: cytologic, anoscopic and histologic correlation. Cancer 2004;102:19-26.
7. Goldman S, Auer G, Erhardt K, Seligson U. Prognostic significance of clinical stage, histologic grade, and nuclear DNA content in squamous-cell carcinoma of the anus. Dis Colon Rectum 1987;30:444-8.
8. Etienney I, Balaton A, Daniel F, Sultan S, Bauer P, Atienza P. Anal cytology: feasibility and tolerance. First results from a pilot study. Gut 2005;37(Suppl 1):A143.
9. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
10. Palefsky JM, Holly E, Ralston MR, Jay N, Berry JM, Darragh TM. High incidence of anal high grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998;12:495-503.
11. Lampinen TM, Miller ML, Chan K, et al. Randomized clinical evaluation of self-screening for anal cancer precursors in men who have sex with men. CytoJournal 2006;20:3-4.
12. Piketty C, Darragh TM, Da Costa M, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003;138:453-9.
13. Daling JR, Madeleine MM, Johnson LG, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004;101:270-80.
14. Phillips DH, Hewer A, Schoelefield JH, Skinner P. Smoking-related DNA adducts in anal epithelium. Mutat Res 2004;560:167-72.
15. Vadjic CM, Anderson JS, Hillman RJ, et al. Blind sampling is superior to anoscope guided sampling for screening for anal intraepithelial neoplasia. Sex Transm Infect 2005;81:415-8.
16. Lemarchand N, Tanne F, Aubert M, et al. Is routine pathologic evaluation of hemorrhoidectomy specimens necessary? Gastroenterol Clin Biol 2004;28:659-61.
17. Bauer P, de Parades V, Etienney I, Daniel F, Atienza P. A propos de "Is routine pathologic evaluation of hemorroidectomy specimens necessary ?" fond et sémantique. Gastroenterol Clin Biol 2005;29:213-4.
18. Arain S, Walts AE, Thomas P, Bose S. The anal Pap smear: cytomorphology of squamous intraepithelial lesions. CytoJournal 2005;2:4.
19. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999;281:1822-9.
20. Lytwyn A, Salit IE, Raboud J, et al. Interobserver agreement in the interpretation of anal intraepithelial neoplasia. Cancer 2005;103:1447-56.
21. Mathews WC, Sitapati A, Caperna JC, Barber RE, Tugend A, Go U. Measurement characteristics of anal cytology, histopathology, and high-resolution anoscopic visual impression in an anal dysplasia screening program. J Acquir Immune Defic Syndr 2004;37:1610-5.
22. Palefsky JM, Holly EA, Hogeboom CJ, et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:314-9.